Jaykay Enterprises Q4 FY26 PAT Surges to ₹179.82 Cr on 322% Income Growth
Jaykay Enterprises reported a strong Q4 FY26 with PAT at ₹179.82 Cr, up from ₹(4.41) Cr YoY, on a 322% income jump to ₹69.78 Cr. For FY26, PAT was ₹215.65 Cr, with income up 185% to ₹282.30 Cr. The company acquired Patange Industries and expanded its Defence & Aerospace segment.
The substantial financial growth, strategic acquisition of a defence manufacturing business, and significant expansion in high-growth sectors like Defence & Aerospace and medical technology are expected to have a material positive impact on the company's future performance and market position.
The company reported significant year-on-year growth in total income, EBIDTA, and profit after tax for both the quarter and the full financial year. Strategic acquisitions and business expansions in key sectors like Defence & Aerospace further strengthen the positive outlook.
Jaykay Enterprises Limited has announced its consolidated financial results for the quarter and financial year ended March 31, 2026. For the fourth quarter of FY2025-26, the company reported a total income of ₹69.78 crore, a significant increase of 322% from ₹16.53 crore in the same quarter last year. EBIDTA also saw a substantial rise of 213% to ₹2.88 crore, compared to ₹0.92 crore in Q4 FY2024-25. Profit After Tax (PAT) post exceptional items stood at ₹179.82 crore, a dramatic turnaround from a loss of ₹(4.41) crore in the prior year's quarter. The exceptional item includes an investment in JK Urbanscapes Developers Ltd. valued at ₹262.66 crore.
For the full financial year ended March 31, 2026, total income grew by 185% YoY to ₹282.30 crore from ₹98.94 crore in FY2024-25. EBIDTA increased by 274% YoY to ₹66.89 crore. Profit before Tax (excluding exceptional items) surged by 529% to ₹44.59 crore, while Profit After Tax (PAT) including exceptional items reached ₹215.65 crore.
The company highlighted significant progress in its Defence & Aerospace division, securing orders from major organizations like BrahMos Aerospace, Bharat Dynamics, and Hindustan Aeronautics. Expansion of the Cherlapally facility was completed, and the Devanahalli facility is progressing as scheduled. In April 2026, Jaykay Enterprises acquired the business undertaking of Patange Industries Pvt. Ltd., strengthening its defence precision manufacturing capabilities.
In the Digital Manufacturing & Advanced Systems segment, the company completed the Peenya orthopaedic implant manufacturing project, achieving CDSCO MD13 certification and commencing trial production. It also secured ISO 13485 certification and made progress in defence-related product development using additive manufacturing. The Digital Services division saw successful deployment of its AI orchestration platform, JIVA, in the US and Europe, and strengthened its offerings with GenAI and Agentic AI solutions.
Mr. Abhishek Singhania, Chairman and Managing Director, stated that FY 2025-26 was a landmark year, marking a strategic evolution into a high-value, technology-driven manufacturing and solutions company. He expressed optimism for hyper-growth in the coming years, supported by expanded manufacturing capabilities.
What to do with a filing like this
Jaykay Enterprises Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jaykay Enterprises Limited. Read the original for the full detail.